As CAPN14-mediated degradation is likely a common EoE mechanism not limited to mutations in DSP and PPL, these findings may substantiate the potential therapeutic value of calpain inhibitors in modifying the identified genetic pathway. Here, CAPN14 is linked to eosinophilic esophagitis.